Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.06
+0.12 (0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
20.00
-0.06 (-0.30%)
After-hours: Apr 28, 2026, 4:56 PM EDT
Denali Therapeutics Employees
Denali Therapeutics had 503 employees as of December 31, 2025. The number of employees increased by 81 or 19.19% compared to the previous year.
Employees
503
Change (1Y)
81
Growth (1Y)
19.19%
Revenue / Employee
n/a
Profits / Employee
-$1,018,966
Market Cap
3.18B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 258 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Edgewise Therapeutics | 146 |
| Tango Therapeutics | 137 |
DNLI News
- 22 days ago - Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why - Benzinga
- 25 days ago - Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN) - GlobeNewsWire
- 4 weeks ago - Denali Therapeutics Transcript: Study update - Transcripts
- 4 weeks ago - Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II) - GlobeNewsWire
- 6 weeks ago - Denali Therapeutics Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 7 weeks ago - Denali Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - FDA reversals leave investors worrying about the fates of other experimental drugs - CNBC
- 7 weeks ago - Denali Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts